Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2

2(40.0%)

N/A

1(20.0%)

Early Phase 1

1(20.0%)

Phase 1

1(20.0%)

5Total

Phase 2(2)

N/A(1)

Early Phase 1(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06788080Early Phase 1Completed

Optimization of Biotinylation Protocol for Studies of Red Blood Cell Survival and Function After Transfusion

Role: lead

NCT04421404Phase 2Completed

Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients

Role: collaborator

NCT02094118Phase 1Completed

Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications

Role: collaborator

NCT01681420Not ApplicableCompleted

Improving Blood Safety and HIV Testing in Brazil

Role: lead

NCT01555060Phase 2Completed

Hemoglobin and Iron Recovery Study

Role: collaborator

NCT00400192Completed

Transfusion-Associated Microchimerism in Individuals Receiving a Blood Transfusion After a Traumatic Injury

Role: lead

NCT01094197Withdrawn

Detailed Evaluation of Microchimerism

Role: lead

All 7 trials loaded